Bio-Techne Corp.

Bio-Techne Corp.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
37.73 M
Public Float
36.87 M
Bio-Techne Corp.
Stock Exchange NASDAQ Stock Market
EPS
$3.11
Market Cap
$8.14 B
Shares Outstanding
37.87 M
Public Float
37.26 M

Profile

Address
614 McKinley Place NE
Minneapolis Minnesota 55413
United States
Employees -
Website http://www.bio-techne.com
Updated 07/08/2019
Bio-Techne Corp. engages in the development, manufacture and sale of biotechnology reagents and instruments for the research and clinical diagnostic markets. It operates through the following segments: Biotechnology, Protein Platforms, Diagnostics, and Corporate. The Biotechnology segment supplies specialized proteins, such as cytokines and growth factors, immunoassays, antibodies and related reagents, as well as in situ hybridization, media and other cell culture products and reagents to the biotechnology research community.

Financials

View All

Charles R. Kummeth
President, Chief Executive Officer & Director
Joseph D. Keegan
Director